Waldencast plc
WALDConsumer DefensiveNASDAQHousehold & Personal Products · Last scanned Jul 22, 2026
Scan Results
Daily timeframeWaldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. Valued at $230.9M, WALD is a micro-cap name in its sector. The company operates through two segments, Obagi Medical and Milk Makeup.
Market Cap
$230.9M
Beta
-0.04
P/E (TTM)
—
P/E (Fwd)
-2.25
EPS (TTM)
$-2.14
EPS (Fwd)
$-0.80
ROE
-40.3%
ROA
-4.7%
Cash
$30.4M
Total Debt
$149.0M
Free CF
$115.2M
52W Change
-25.9%
Annual Financials
Cash vs Debt
Where WALD stands vs its 150-day and 200-day moving averages
As of the July 15, 2026 close, WALD finished 16.23% above its 150-day moving average ($1.54) and 7.19% above its 200-day moving average ($1.67). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is WALD overbought or oversold?
At the July 15, 2026 close, WALD's RSI(14) was 60.2, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $30.4M in cash, though total debt stands at $149.0M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $115.2M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at -40.3%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $142.5M (2021) to $272.1M (2025), reflecting a 91% increase over the period.
With a beta below 0.7, Waldencast plc typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Waldencast plc's trajectory.